Robotic Surgery in Colorectal Cancer
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Clinical Research of Cancer".
Deadline for manuscript submissions: 31 December 2024 | Viewed by 811
Special Issue Editor
Special Issue Information
Dear Colleagues,
Many colorectal cancer patients have benefited from minimally invasive surgery. To a certain extent, the adoption and applicability of conventional laparoscopy have been curtailed by the technical limitations imposed by the equipment. Robotic surgery has been developed to address some of these issues. While early studies on robotic surgery in colorectal cancer focused on its feasibility and safety, more contemporary studies have sought to compare its outcomes with laparoscopy—in particular, its cost effectiveness.
We are pleased to invite you to contribute original research or review articles to this Special Issue, focusing on the use of robotic surgery in colorectal cancer and how recent data have helped us to distinguish it from conventional laparoscopy. Studies addressing the clinical outcomes, ergonomics, and costs are welcomed.
Dr. James Chi Yong Ngu
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- robotic surgery
- colorectal cancer
- minimally invasive surgery
- therapeutic endoscopy
- laparoscopy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
Planned Papers
The below list represents only planned manuscripts. Some of these manuscripts have not been received by the Editorial Office yet. Papers submitted to MDPI journals are subject to peer-review.
Title: Robotic-Assisted Colon Cancer Surgery: Faster Recovery and Fewer Complications Compared to Laparoscopy in retrospective propensity matching study
Authors: Chun-Yu Lin a,b*, Yi-Chun Liu a,c,d*, Chou-Chen Chen b,d , Ming-Cheng Chen b, e, Teng-Yi Chiu b, Yi-Lin Huang b, Shih-Wei Chiang b, Chang-Lin Lin b, Ying-Jing Chen b, Chen-Yen Lin b, Jin-Ching Lin a,c
Affiliation: a.Institute of Clinical Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan
b.Division of Colorectal Surgery, Department of Surgery, Taichung Veterans General Hospital,Taichung, Taiwan
c.Department of Radiology, Taichung Veterans General Hospital, Taichung, Taiwan
d.Department of Post-Baccalaureate Medicine, College of Medicine, National Chung Hsing University, Taichung, Taiwan
e.School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan
f. Department of Radiation Oncology, Changhua Christian Hospital, Changhua, Taiwan
g. College of humanities and social sciences, Providence University, Taichung, Taiwan
Abstract: Background
Colorectal cancer (CRC) is one of the most common cancers worldwide, ranking third in incidence and
second in cancer-related deaths globally. In 2020, the global incidence of CRC was approximately 1.9
million new cases annually. Colon cancer accounts for around 60% of all CRC cases. Surgery is the optimal
treatment for stage I-III colon cancer. Minimally invasive techniques, such as robotic-assisted surgery (RAS)
and laparoscopic surgery (LSS), can reduce recovery time and minimize complications. The choice between
these techniques for colon cancer resection often depends on the surgeon and the facilities available. This
study analyzes perioperative outcomes between RAS and LSS in colon cancer resections.
Material and Methods
Between January 1, 2018, and February 29, 2023, we retrospectively collected data on colon cancer patients
with clinical stage I-III who underwent elective colon resection via either robotic-assisted or laparoscopic
surgery. Preoperative characteristics, intraoperative outcomes, and postoperative recovery indicators were
gathered and compared between the two groups. The primary outcome was recovery time , while the
secondary outcome was surgery-related complications. Data analysis was conducted from June 1 to August
15, 2024.
Result
A total of 179 robotic-assisted surgeries and 652 laparoscopic surgeries were analyzed. After propensity
matching for gender, age, lesion site, and ASA score, there were 179 cases in the RAS group and 358 cases
in the LSS group. RAS was associated with significantly longer operative times (mean: 284.4 ± 66.5 vs.
209.5 ± 85.2 minutes, p<0.001) but fewer conversions to open surgery (0.6% vs. 3.9%, p=0.026).
Postoperative recovery was faster in the RAS group, with earlier initiation of drinking, eating, and bowel
movements, and shorter hospital stays (5.8 ± 4.9 vs. 9.2 ± 6.2 days, p<0.001). A higher proportion of
textbook outcomes was also noted. The diuretic phase occurred earlier in the RAS group (1.0 vs. 3.0 days,
p=0.001), and postoperative pain scores were significantly lower in the RAS group (3.1 vs. 5.0, p=0.001).
RAS was associated with lower rates of minor complications, including significantly fewer instances of ileus
(8.4% vs. 21.5%, p<0.001) and chyle leakage (0% vs. 2.1%, p=0.049). There was a trend toward fewer
cardiovascular events (0.0% vs. 2.2%, p=0.057), pneumonia (3.4% vs. 5.7%, p=0.255), and urinary tract
infections (1.1% vs. 2.8%, p=0.353) in the RAS group. The risk of major complications was similar between
the groups (4.5% vs. 5.3%, p=0.675), with identical anastomotic leakage rates (2.2% vs. 2.2%, p=1.000).
However, the readmission rate was higher in the RAS group (10.6% vs. 6.1%, p=0.066), primarily due to
minor complications (83.3%).
Conclusions
Robotic-assisted surgery for colon cancer demonstrates significant advantages in terms of faster recovery,
less postoperative pain, and fewer minor complications compared to conventional laparoscopic surgery.